Centessa Pharmaceuticals (NasdaqGS:CNTA) FY Conference Transcript
Centessa Pharmaceuticals (NasdaqGS:CNTA) FY Conference November 12, 2025 10:30 AM ET Speaker0Good morning, and thank you for joining Guggenheim's 2025 Healthcare Innovations Conference. I am Devjit, one of the therapeutic analysts, and my privilege to welcome our next presenting company, Centessa Pharmaceuticals. Joining us from Centessa are Saurabh Saha, CEO, and Mario Accardi, President of the Orexin Program. Thank you, gentlemen, for making time for us.Speaker2Thank you.Speaker1Thank you.Speaker0You're n ...